Cancer Vaccine / Russia's cancer vaccine passed, people can use it after one stamp

Cancer Vaccine: Russia has taken an important step in the treatment of cancer. Veronika Skvortsova, head of Russia's Federal Medical and Biological Agency, recently announced that their mRNA-based cancer vaccine has succeeded in preclinical trials and is now ready for use. In these trials that lasted for three years, the vaccine has been found to be safe and effective. This vaccine can be a revolutionary step in the fight against cancer.

Features of the vaccine

• mRNA technology: This vaccine is based on mRNA technology, which will be prepared individually based on the RNA of each patient. This personalized approach makes it more effective.
• Impressive results: Researchers observed a reduction in tumor size by 60% to 80% during trials. The vaccine gave great results even after repeated use.
• Targeted cancer: Initially this vaccine will target colorectal cancer. Apart from this, good progress has also been made in the development of vaccines for glioblastoma and various types of melanoma.
• Eliminate the need for chemotherapy: If the vaccine gets official approval, it can eliminate the need for chemotherapy, which will be a big relief for patients.

Russia's contribution and global race

Russia's achievement is part of the ongoing research in the field of cancer vaccine globally. Britain is working on a cancer vaccine in collaboration with Germany's BioNTech, while US pharmaceutical companies Moderna and Merck are developing vaccines for skin cancer. Russia's mRNA vaccine is an important step in this race, which promotes personalized treatment.

Increasing risk of cancer in India

Cancer has become a serious health challenge in India. According to the Indian Council for Medical Research (ICMR), 8.74 lakh people died due to cancer in 2024, including 4.60 lakh men and 4.14 lakh women. The number of cancer patients is expected to increase by 12% in the next five years. Cancer cases are increasing rapidly, especially among younger people. According to a research in the Nature journal, the biggest reason behind this is our changing lifestyle, which includes poor eating habits, stress and environmental factors.

Future prospects

This Russian vaccine not only raises a new hope in the treatment of cancer, but also shows that mRNA technology can now be used beyond infectious diseases to also be used against complex diseases like cancer. Veronika Skvortsova said that the vaccine is awaiting official approval, after which it can be available to patients.

In countries like India, where cancer cases are increasing rapidly, such a vaccine can prove to be a game-changer. However, for its widespread use, aspects like cost, distribution and awareness will also have to be taken into account.